obesity

  1. madman

    Hypogonadotropic Hypogonadism in Men with Obesity and Diabetes

    Dr. Dhindsa! Tulane Center of Excellence in Sex-based Biology & Medicine Seminar Series Summary
  2. madman

    Treating obesity & preventing type 2 diabetes in people living with HIV

    Jennifer Manne-Goehler, HIV clinician-scientist at the Brigham and Women's Hospital and Assistant Professor of Medicine at Harvard Medical School, talks to us about the cardiometabolic complications of HIV, specifically cardiovascular disease, diabetes, and weight loss strategies for people...
  3. madman

    Oral vs Injectable: Navigating Patient Choice in Weight Management

    Discover oral incretins as alternatives in obesity care.
  4. madman

    Beyond Weight Loss–Effects of Obesity & GLP-1 /dual Agonists on Sexual Function

  5. madman

    Managing GLP-1 Side Effects and Endoscopy Risks

    Drs Benjamin Levy III and Michael Camilleri discuss managing GLP-1 gastrointestinal adverse effects, preparing patients for endoscopy, and treating obesity.
  6. madman

    How Testosterone Changes Your Metabolism

    Testosterone influences far more than just libido and muscle growth: In this episode, Dr. Jonathan Apasu speaks with Prof. Farid Saad about the crucial role of testosterone in metabolism, insulin resistance, prediabetes, diabetes, and obesity. Together, they explain why testosterone deficiency...
  7. madman

    Can long-term testosterone therapy in men with class III obesity be an alternative to metabolic surgery?

    * Dr Saad says: “Long-term testosterone therapy in hypogonadal men resulted in profound and sustained in weight loss which may have contributed to reductions in mortality and cardiovascular events. Untreated men with hypogonadism gained weight.” * Dr Saad says: “Long-term testosterone therapy...
  8. madman

    Weight loss and Testosterone Deficiency: T Therapy + GLP-1

    32:00-44:15 Case: 54-Year-Old Man with Vaculogenic ED Case Study: Body Composition Transformation THE EFFECTS OF COMBINED THERAPY ON HORMONAL AND METABOLIC PERFORMANCE DATA-DRIVEN INSIGHTS: QUANTITATIVE BIOMARKER CHANGES...
  9. madman

    Managing MASH in the Modern Era

    Christina Hanson, FNP-C, MSN, discusses best practices for screening individuals for metabolic dysfunction-associated steatohepatitis (MASH).
  10. madman

    What Drives Early-Onset Colorectal Cancer? An Expert Explains

    What role do diet, obesity, the microbiome, and screening play in early-onset colorectal cancer? Dr Benjamin Levy and Dr Aasma Shaukat discuss the latest evidence.
  11. madman

    TRT, GLP-1s, and peptides: How to counsel patients stacking longevity therapies

    Rising patient interest in TRT, GLP-1s, and peptide stacking requires clinicians to anchor conversations in evidence tiers, use baseline DEXA scans to monitor body composition, and engage patient goals without endorsing unsupported claims, according to Jean Cunningham, PharmD, BCPS...
  12. madman

    Inside the GLP-1 Revolution: Hope, Hype, and the Future of Obesity Care

    * They unpack the myths, the mechanisms, and the real impact behind these breakthrough therapies, and don’t shy away from the harder questions around access, affordability From Hollywood headlines to hospital hallways, the world’s sudden fascination with GLP-1s makes it hard to separate...
  13. madman

    GLP-1s—From Gut Hormone Discovery to a Public Health Revolution: Should Everyone be on GLP-1s?

    GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and development of...
  14. madman

    How Does My Metabolic Health Affect My Sexual Health?

    There are many benefits to maintaining strong metabolic health, including weight management, a strong immune system, and reduced risk for chronic disease. But what does your metabolic health have to do with your sexual health? Ask a Sexpert! In this video, Dr. Taylor Kohn unpacks the impact of...
  15. madman

    Ozempic, Wegovy, Mounjaro & Zepbound Muscle Mass Worries

    Semaglutide, sold as Ozempic and Wegovy, and tirzepatide, sold as Zepbound and Mounjaro, are new therapies for weight loss that actually work, helping millions around the world to feel better. But some people are fearful of side effects, such as loss of muscle mass. Are their fears warranted...
  16. madman

    The Future of Weight Loss Drugs: Survodutide & Retatrutide. Ozempic & Mounjaro are the beginning.

    * Dr. le Roux shares exclusive insights into the Phase 3 data for #Survodutide (Boehringer Ingelheim’s dual GLP-1/glucagon agonist), including its groundbreaking impact on visceral fat and #FattyLiverDisease (MASLD/MASH) via the SYNCHRONIZE trials. In this #DoctorPodcasts Episode 149, we...
  17. madman

    Survodutide in Obesity: 25% REDUCTION IN SUBCUTANEOUS FAT, 34% REDUCTION IN VISCERAL FAT and 63% REDUCTION IN LIVER FAT

    Truly impressive! * the really exciting data of SYNCHRONIZE-1 was not the weight loss it was actually the metabolic health gains so we see that there was an improvement in glycemia and blood pressure but there was a. 63% REDUCTION IN FAT IN THE LIVER so imagine you had 16% weight loss but 25%...
  18. madman

    Ozempic, GLP-1s and the Future of Obesity - Prof. Carel Le Roux

    Carel le Roux is a Professor of Experimental Pathology at University College Dublin, Director of the Metabolic Medicine Group, and one of the world's leading researchers on how the gut communicates with the brain. He completed his PhD at Imperial College London, where he conducted foundational...
  19. madman

    Testosterone and sperm may get a boost from obesity drugs

    Nature staff discuss preliminary data on the effects of GLP-1 drugs on male fertility, plus a two-year trial of a brain-computer interface. Timestamps 00:18 Brain-computer interface makes a life-changing impactNature: At-home brain implant gives man with motor neuron disease his daily life...
  20. madman

    Unlocking the Potential of Incretin-Based Therapies in T2D

    Incretin-Based Therapies Goals for Today
  21. madman

    Testosterone Treatment in Prediabetes and Obesity: Cases and Review of Literature

    , discusses : : . ,
  22. madman

    Testosterone Levels Improve in Men under GLP-1 Receptor Agonist Therapy

    Dr. Andres Guillen Lozoya discusses findings from, "Testosterone Levels Improve in Men under GLP-1 Receptor Agonist Therapy.” This study aimed to evaluate changes in total and free testosterone before and after GLP-1RA therapy in men
  23. madman

    GLP-1 drugs are entering a new chapter

    In this episode of Science Quickly, Scientific American’s associate health editor Lauren Young joins host Kendra Pierre-Louis to talk about how the story of GLP‑1 drugs such as Ozempic, Wegovy and Mounjaro is evolving. We trace GLP-1s’ origins as type 2 diabetes treatments, their rise as...
  24. madman

    The Ultimate GLP-1 Guide: Weight Loss, Side Effects & Sarcopenia Risk

    Are GLP-1 agonists like Ozempic and Mounjaro the future of healthcare or a risk to your health? We break down the latest data on weight loss medication efficacy, common side effects, and the truth about muscle mass loss (sarcopenia). In This Episode: Dr. Jordan Feigenbaum and Dr. Austin...
  25. madman

    The GLP-1 Paradox in Colorectal Cancer

    In this video, David Kerr, MD examines the complex relationship between GLP-1 receptor agonists and gastrointestinal health. While these agents are highly effective for treating type 2 diabetes and obesity, a large-scale meta-analysis of over five million individuals suggests a nuanced...
  26. madman

    Relationship between erectile dysfunction metabolic syndrome

    Dr. Corona another powerhouse in the field! * The current video summarizes and critical analyzes available evidence from the first reports to a recently updated meta-analysis [1]. Data derived from a meta-analytic approach, including 25 studies and 18,237 subjects showed that MetS was...
  27. madman

    Obstructive Sleep Apnea: Diagnosis, Treatment, and Cardiovascular Implications

    In this SCCR Science Series session, Elaine Costa, MD, a postdoctoral scholar in the Department of Otolaryngology, Head, and Neck Surgery (OHNS) provides an overview of obstructive sleep apnea (OSA). Here she covers:
  28. madman

    How to treat obesity and hypogonadism; The male hormone reset

    Professor Michael Zitzmann Testosterone Deficiency (TD). and its Effects https://www.excelmale.com/threads/the-male-hormone-reset-how-glp-1ras-lifestyle-and-testosterone-transform-obesity-linked-problems.33386/
  29. madman

    The Science Behind the New Wegovy Pill

    What actually makes a GLP-1 pill work in the real world—and why does taking it come with such specific rules? And if these meds improve health beyond weight, why does the conversation still get stuck on the scale?Dr. Emily Cooper, Mark Wright, and Andrea Taylor sit down with Novo Nordisk’s Dr...
  30. madman

    Metabolic Syndrome and Cardiovascular Risk: Obesity, Diabetes, Dyslipidemia, and Sexual Health as an Early Marker of Systemic Disease

    Dr. Peter Wilson I am going to give you some pearls from recent talks. 1:28-2:19 * Shehzad Basaria from Harvard who's on the TRAVERSE Trial. He said one of the biggest mistakes were making is assuming free testosterone is correct. Thats important and I think we in endocrinology and urology...
  31. madman

    Exhausted or Undiagnosed? The Truth About OSA

    Think sleep apnea is just for "middle-aged men who snore?" Think again. Dr. Kimberly Sterling and Dr. Audrey Wells join us to reveal why 90% of women are living with undiagnosed sleep apnea and how "invisible" symptoms like fatigue and anxiety are masking a life-threatening breathing disorder.
Free ExcelMale Downloads: men's health guides, eBooks and resources

Sponsors

obesity

obesity

ExcelMale Newsletter Signup

Back
Top